Powder: -20°C for 3 years | In solvent: -80°C for 1 year
CX516 (Ampalex), an ampakine and nootropic, acts as an AMPA receptor positive allosteric modulator as a therapy for Alzheimer's disease, schizophrenia and mild cognitive impairment (MCI).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | In stock | $ 32.00 | |
10 mg | In stock | $ 52.00 | |
25 mg | In stock | $ 63.00 | |
50 mg | In stock | $ 98.00 | |
100 mg | In stock | $ 126.00 | |
200 mg | In stock | $ 225.00 | |
500 mg | In stock | $ 377.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 47.00 |
Description | CX516 (Ampalex), an ampakine and nootropic, acts as an AMPA receptor positive allosteric modulator as a therapy for Alzheimer's disease, schizophrenia and mild cognitive impairment (MCI). |
Synonyms | Ampakine CX516, BDP 12, Ampalex |
Molecular Weight | 241.29 |
Formula | C14H15N3O |
CAS No. | 154235-83-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 50 mg/mL (207.22 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
CX516 154235-83-3 Membrane transporter/Ion channel Neuroscience iGluR GluR BDP-12 receptor Ionotropic glutamate receptors modulator Ampakine CX 516 CX-516 schizophrenia CX 516 positive AMPA inhibit allosteric Alzheimer Ampakine CX-516 BDP12 Ampakine CX516 BDP 12 Ampalex Inhibitor ampakine inhibitor